Fresenius Medical Care | FME - الأصول





الأصول تغيير تاريخ
Akzo Nobel EUR 16.02B 114M 2026-09
Alcon AG USD 31.1B 521M 2026-06
AstraZeneca USD 119.92B 4.09B 2026-09
Bayer EUR 113.47B 6.18B 2026-09
Beiersdorf EUR 13.32B 560M 2026-06
DaVita Healthcare Partners USD 17.82B 107.02M 2026-09
Demant DKK 40.03B 951M 2026-06
E.ON EUR 120.7B 5.26B 2026-09
Essilor EUR 65.06B 1.16B 2026-06
Fresenius EUR 42.24B 401M 2026-09
Fresenius Medical Care EUR 31.45B 155.97M 2026-09
Genmab DKK 12.52B 139M 2026-06
Getinge SEK 57.37B 6.55B 2026-06
Givaudan CHF 11.86B 587M 2025-12
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
GN Store Nord DKK 30.31B 762M 2026-09
GRIFOLS EUR 20.28B 191M 2026-09
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Lonza CHF 18.97B 164M 2025-12
Merck EUR 52.69B 383M 2026-06
Novartis USD 117.15B 4.88B 2026-09
Philips EUR 28.03B 1.33B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
RWE EUR 129.78B 14.05B 2026-09
Sanofi EUR 130.29B 1.23B 2026-09
SAP EUR 76.34B 727M 2026-09
Smith & Nephew USD 11.01B 321M 2026-06